Limitations of molecular testing in combination with computerized tomographic for lung cancer screening von Grannis, Frederic W.

Volltext

Do Cancer Screening Researchers Have a Continuing Ethical Obligation to Their Study Subjects? von Grannis, Frederic W.

Volltext

Lung Cancer Incidence and Mortality with Extended Follow-up during Screening von Grannis, Frederic W.

Volltext

Five-Year Lung Cancer Survival: Which Advanced Stage Nonsmall Cell Lung Cancer Patients Attain Long-Term Survival? von TINA WANG, NELSON, Rebecca A, BOGARDUS, Alicia, GRANNIS, Frederic W

Volltext

Longitudinal Changes in Function, Symptom Burden, and Quality of Life in Patients with Early-Stage Lung Cancer von Koczywas, Marianna, Williams, Anna Cathy, Cristea, Mihaela, Reckamp, Karen, Grannis Jr, Frederic W., Tiep, Brian L., Uman, Gwen, Ferrell, Betty

Volltext

Are We Underestimating Efficacy and Cost-Efficacy of Population Lung Cancer Computed Tomography Screening? von Grannis, Frederic W.

Volltext

Minimizing over-diagnosis in lung cancer screening von Grannis Jr, Frederic W.

Volltext

Natural history of typical pulmonary carcinoid tumors: a comparison of nonsurgical and surgical treatment von Raz, Dan J, Nelson, Rebecca A, Grannis, Frederic W, Kim, Jae Y

Volltext

National lung screening trial limitations and public health policy von Grannis, Jr, Frederic W

Volltext

Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non–Small-Cell Lung Cancer von ALTORKI, Nasser, LANE, Maureen E, MITCHELL, John D, TACHDJIAN, Sabrina, SUZANNE SWANN, R, HUFF, Anne, ROYCHOWDHURY, Debasish F, REEVES, Anthony, OTTESEN, Lone H, YANKELEVITZ, David F, BAUER, Thomas, LEE, Paul C, GUARINO, Michael J, PASS, Harvey, FELIP, Enriqueta, PEYLAN-RAMU, Nili, GURPIDE, Alfonso, GRANNIS, Frederic W

Volltext

Musings of a cynical curmudgeon: Pain or feign? von Grannis, Jr, Frederic W

Volltext

Methodologists are not qualified to write clinical guidelines von Grannis, Frederic W

Volltext

Is Primary Resection of Stage IIIA Lung Cancer Futile? von Grannis, Frederic W., MD

Volltext

Minimal Survival After Chemoradiation Therapy for “Non-Bulky” Stage IIIA NSCLC: What Are the Implications? von Grannis, Frederic W., MD

Volltext

Skin carcinogenesis and driving von Cameron, Hugh, MBA, Grannis, Frederic W., MD

Volltext

Survival following lung resection in immunocompromised patients with pulmonary invasive fungal infection von Wu, Geena X., Khojabekyan, Marine, Wang, Jami, Tegtmeier, Bernard R., O'Donnell, Margaret R., Kim, Jae Y., Grannis, Frederic W., Raz, Dan J.

Volltext

Treatment of Chylothorax by Robotic Thoracic Duct Ligation von Thompson, Kari J., MD, Kernstine, Kemp H., MD, PhD, Grannis, Frederic W., MD, Mojica, Pablo, MD, Falabella, Andres, MD

Volltext

Natural History of Typical Pulmonary Carcinoid Tumors von Raz, Dan J., MD, MAS, Nelson, Rebecca A., PhD, Grannis, Frederic W., MD, Kim, Jae Y., MD

Volltext

Augmented Meaningful Use Criteria to Identify Patients Eligible for Lung Cancer Screening von Raz, Dan J., MD, Dunham, Rachel, NP, Tiep, Brian, MD, Sandoval, Argelia, MD, Grannis, Frederic, MD, Rotter, Arnold, MD, Kim, Jae Y., MD

Volltext

Invited Commentary von Grannis, Frederic W.

Volltext